NCT05635604 Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients. Status COMPLETED Phase NA
NCT05568004 The Effect of Different Exercise Types on Migraine Frequency in Individuals With Migraine Status COMPLETED Phase NA
NCT05561660 COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2) Status UNKNOWN Phase PHASE4
NCT05556564 The Impact of Migraine on Canadians' Productivity: A Real-World Pharmacy-Based Study Status COMPLETED Phase N/A
NCT05550207 Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE) Status COMPLETED Phase PHASE3
NCT05546320 Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale Status COMPLETED Phase PHASE2
NCT05518123 Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications Status COMPLETED Phase PHASE4
NCT05509400 Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use Status COMPLETED Phase PHASE4
NCT05492695 Tandem OnabotulinumtoxinA Galcanezumab Emerging Therapeutic Headache Elimination Research Study Status TERMINATED Phase PHASE4
NCT05477095 A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants Status COMPLETED Phase PHASE1
NCT05468801 Efficacy of Individualized Homeopathic Remedies on Migraine: a Randomized, Triple-blind, Placebo Controlled Study. Status UNKNOWN Phase NA